Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07896681
Recruiting
Toripalimab Plus Cetuximab and Irinotecan for Second-Line Right-Sided RAS/BRAF Wild-Type Advanced Colon Cancer Phase II Study
Phase 2 · China · 1 site
Registry update: 27 Oct 2026
NCT07655622
Recruiting
Vebreltinib Plus Furmonertinib in Patients With EGFR-mutated Advanced Non-small Cell Lung Cancer and High PD-L1 Expression
Phase 1/2 · China · 1 site
Registry update: 18 Jun 2026
NCT07274254
Recruiting
Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease
Phase 3 · France, Guadeloupe · 12 sites
Registry update: 9 Sept 2026
NCT07600476
Recruiting
A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors
Phase 1 · Germany · 6 sites
Registry update: 12 Aug 2026
NCT07211438
Recruiting
Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression
Phase 2 · Canada · 2 sites
Registry update: 21 Aug 2026
NCT07744022
Recruiting
Effects of Progressive Neuromuscular Stabilization Exercises Versus Aerobic Exercises on Body Composition and Postural Balance in Children With Obesity
Not applicable · 1 site
Registry update: 4 Aug 2026
NCT07696533
Recruiting
ULTIMATE Study (Carotid Ultrasound Vs CT Coronary Calcium Scoring to Reclassify Symptomatic Patients With Chronic Coronary Syndrome)
Not applicable · United Kingdom · 1 site
Registry update: 15 Jul 2026
2025-521437-88-00
Recruiting
Phase II study of ficerafusp alfa in combination with nivolumab in patients with platinum-refractory head and neck squamous cell carcinoma who progressed within 6 months of multimodality therapy for locally advanced disease.
Phase 2 · France · 24 sites
Registry update: 12 Oct 2026
2025-524899-40-00
Recruiting
A First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of MR-L45 in Healthy Adults
Phase 1 · Netherlands · 1 site
Registry update: 20 Aug 2026
NCT07567794
Recruiting
GBPDC: Gut-Brain in PD Consortium Master Protocol
Not applicable · United States · 7 sites
Registry update: 25 Sept 2026
NCT07365241
Recruiting
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Phase 3 · Austria, Belgium, Brazil, Switzerland, Germany, Spain, France, Greece, Italy, Japan, United States · 102 sites
Registry update: 23 Sept 2026
NCT07667504
Recruiting
Dietary Approaches for the Management of Overweight and Obesity in Type 1 Diabetes
Not applicable · Spain · 1 site
Registry update: 15 Jul 2026
NCT07539844
Recruiting
Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries
Not applicable · Argentina, Brazil, Canada, Colombia, Mexico · 12 sites
Registry update: 14 Sept 2026
NCT07566325
Recruiting
Assess the Effects of Replacing Foods High in Refined Carbohydrates With Avocado on Biomarkers of Inflammation.
Not applicable · United States · 2 sites
Registry update: 27 Aug 2026
NCT07362446
Recruiting
Prevention of Reperfusion Injury Outcomes Through Effective Cardioprotection Targeting Myocardial Infarction
Phase 2 · Australia · 8 sites
Registry update: 4 Nov 2026
NCT07698899
Recruiting
A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)
Phase 1 · United States · 7 sites
Registry update: 8 Oct 2026
NCT07644364
Recruiting
HJB647 Phase 1b Study in Japanese Healthy Participants With Elevated Blood Pressure and Patients With Hypertension
Phase 1 · Japan · 1 site
Registry update: 22 Jul 2026
NCT07478991
Recruiting
Azacytidine, Venetoclax Plus Minus Quizartinib for First Line Older/Unfit AML Patients (VENP-A-QUI)
Phase 3 · Spain · 52 sites
Registry update: 4 Nov 2026
NCT04401982
Recruiting
Measuring the Effects of Netarsudil, Latanoprost, and Combination Therapy on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects
Phase 4 · United States · 4 sites
Registry update: 2 Jul 2026
NCT07417904
Recruiting
BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
Not applicable · United States · 1 site
Registry update: 29 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.